Previous close | 2.7300 |
Open | 2.7360 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 2.7360 - 2.7400 |
52-week range | 2.6200 - 4.4700 |
Volume | |
Avg. volume | 43,534 |
Market cap | 673.018M |
Beta (5Y monthly) | 1.27 |
PE ratio (TTM) | ∞ |
EPS (TTM) | 0.0000 |
Earnings date | 10 May 2024 - 14 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
WELL Health Technologies Corp. (TSX: WELL) ("the Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce its support of the recently announced reimbursement policies from a number of key Canadian provinces where WELL has significant clinical operations.
HEALWELL debuted in the fourth quarter of 2023 and since then has achieved significant milestones including raising approximately $29.5 million, completing the acquisition of a majority interest in AI healthcare company Pentavere, announcing that it is powering WELL AI Decision Support, the first AI-powered physician co-pilot product adopted by WELL Health Technologies (TSX: WELL), and announcing the acquisition of Intrahealth, an enterprise class EHR driving current yearly run-rate revenues to
WELL Health Technologies Corp. (TSX: WELL) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce its audited consolidated financial results for the fiscal year and fourth quarter ended December 31, 2023.